articleNew England Journal of MedicineJan 12, 2022GREEN OA

Biologic Therapies for Severe Asthma

GGGuy G. BrusselleGHGerard H. Koppelman

University Medical Center Groningen

PubMed
Indexed incrossrefpubmed

Abstract

Patients with severe asthma are at increased risk for a decreased quality of life, fixed airway obstruction, hospitalization, and death. Biologics may be required to reduce the disease burden. This review discusses the mechanisms, efficacy, and safety of biologics for severe asthma.

Citation impact

670
total citations
FWCI
73.67
Percentile
100%
References
82
Citations per year

Authors

2
  • GG
    Guy G. BrusselleCorresponding

    University Medical Center Groningen

  • GH
    Gerard H. Koppelman

    University Medical Center Groningen

Topics & keywords

Keywords
  • Asthma
  • Disease
  • Airway
  • Quality of life (healthcare)
  • Respiratory disease
  • Clinical trial
  • Adrenergic beta-Agonists
No related works found for this paper.